These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 28193660)
21. Antimicrobial resistance trends among canine Escherichia coli isolated at a New York veterinary diagnostic laboratory between 2007 and 2020. Osman M; Albarracin B; Altier C; Gröhn YT; Cazer C Prev Vet Med; 2022 Nov; 208():105767. PubMed ID: 36181749 [TBL] [Abstract][Full Text] [Related]
22. Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. Kahlmeter G; Menday P J Antimicrob Chemother; 2003 Jul; 52(1):128-31. PubMed ID: 12805266 [TBL] [Abstract][Full Text] [Related]
23. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram. Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821 [TBL] [Abstract][Full Text] [Related]
24. Antibiotic resistance pattern of urinary tract isolates of Escherichia coli from Kumaun region. Rawat V; Umesh ; Paul P J Commun Dis; 2010 Mar; 42(1):63-6. PubMed ID: 22468553 [TBL] [Abstract][Full Text] [Related]
25. Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998-2005). Nys S; Terporten PH; Hoogkamp-Korstanje JA; Stobberingh EE; J Antimicrob Chemother; 2008 Jul; 62(1):126-32. PubMed ID: 18417487 [TBL] [Abstract][Full Text] [Related]
26. Clinical implications. In vitro resistance of E coli to TMP/SMX. Postgrad Med; 2001 Aug; 110(2 Suppl):11-5; discussion 26-7. PubMed ID: 19667571 [No Abstract] [Full Text] [Related]
27. Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient Management. Kaye KS; Gupta V; Mulgirigama A; Joshi AV; Scangarella-Oman NE; Yu K; Ye G; Mitrani-Gold FS Clin Infect Dis; 2021 Dec; 73(11):1992-1999. PubMed ID: 34143881 [TBL] [Abstract][Full Text] [Related]
32. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited. Kahlmeter G; Poulsen HO Int J Antimicrob Agents; 2012 Jan; 39(1):45-51. PubMed ID: 22055529 [TBL] [Abstract][Full Text] [Related]
33. Antibiotic treatment and antimicrobial resistance in children with urinary tract infections. Vazouras K; Velali K; Tassiou I; Anastasiou-Katsiardani A; Athanasopoulou K; Barbouni A; Jackson C; Folgori L; Zaoutis T; Basmaci R; Hsia Y J Glob Antimicrob Resist; 2020 Mar; 20():4-10. PubMed ID: 31252156 [TBL] [Abstract][Full Text] [Related]
34. Basic patient characteristics predict antimicrobial resistance in E. coli from urinary tract specimens: a retrospective cohort analysis of 5246 urine samples. Erb S; Frei R; Tschudin Sutter S; Egli A; Dangel M; Bonkat G; Widmer AF Swiss Med Wkly; 2018 Nov; 148():w14660. PubMed ID: 30440065 [TBL] [Abstract][Full Text] [Related]
35. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children. Allen UD; MacDonald N; Fuite L; Chan F; Stephens D CMAJ; 1999 May; 160(10):1436-40. PubMed ID: 10352632 [TBL] [Abstract][Full Text] [Related]
36. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Sahm DF; Thornsberry C; Mayfield DC; Jones ME; Karlowsky JA Antimicrob Agents Chemother; 2001 May; 45(5):1402-6. PubMed ID: 11302802 [TBL] [Abstract][Full Text] [Related]
37. Fluoroquinolone-Resistant Sequence Type 131 Subgroups O25b and O16 Among Extraintestinal Escherichia coli Isolates from Community-Acquired Urinary Tract Infections. Hefzy EM; Hassuna NA Microb Drug Resist; 2017 Mar; 23(2):224-229. PubMed ID: 27214282 [TBL] [Abstract][Full Text] [Related]
38. Activity of Eravacycline against Escherichia coli Clinical Isolates Collected from U.S. Veterans in 2011 in Relation to Coresistance Phenotype and Sequence Type 131 Genotype. Johnson JR; Porter SB; Johnston BD; Thuras P Antimicrob Agents Chemother; 2015 Dec; 60(3):1888-91. PubMed ID: 26666925 [TBL] [Abstract][Full Text] [Related]
39. Antimicrobial resistance trend of bacterial uropathogens at the university of Gondar comprehensive specialized hospital, northwest Ethiopia: A 10 years retrospective study. Kasew D; Desalegn B; Aynalem M; Tila S; Diriba D; Afework B; Getie M; Biset S; Baynes HW PLoS One; 2022; 17(4):e0266878. PubMed ID: 35404978 [TBL] [Abstract][Full Text] [Related]
40. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study. Sotto A; De Boever CM; Fabbro-Peray P; Gouby A; Sirot D; Jourdan J J Clin Microbiol; 2001 Feb; 39(2):438-44. PubMed ID: 11158087 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]